Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F65D4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,642
Award facts
- Contract value 100% obligated
- $10,642.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 7, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, authorizes delivery of Cosentyx (secukinumab) 300mg dose in 2-pen format totaling $10,642.16. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 8, 2026, with performance to be completed in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication used primarily for treating autoimmune inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing a specialized pharmaceutical commodity within the military healthcare supply chain.
This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide. The contract demonstrates AmerisourceBergen's critical role as a pharmaceutical prime vendor, delivering specialty medications and biologics to support Defense Health Agency requirements and other federal medical institutions. As a non-set-aside award, this delivery order was competitively awarded through the open contracting process.
Quick answers
Who was awarded contract SPE2DR26F65D4?
SPE2DR26F65D4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F65D4 worth?
The government has obligated $10,642 on SPE2DR26F65D4.
Is contract SPE2DR26F65D4 an order under another contract?
Yes. SPE2DR26F65D4 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65D4 competed?
The extent of competition for SPE2DR26F65D4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award